01—History
EPS (Diluted) History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- −$3.78
02—Ledger
03—Questions
What is eps (diluted)?
Diluted earnings per share (EPS) can be defined as net income divided by the total number of shares outstanding including all dilutive securities such as stock options, warrants, and convertible bonds.
What is BridgeBio Pharma's current eps (diluted)?
BridgeBio Pharma (BBIO) annual eps (diluted) for 2025 was $-3.78, a 31.25% decline from 2024. BridgeBio Pharma eps (diluted) for the quarter ending September 30, 2026 was $-0.42.
What was BridgeBio Pharma's eps (diluted) in 2024?
BridgeBio Pharma annual eps (diluted) for 2024 was $-2.88, a 27.09% increase from 2023.
What was BridgeBio Pharma's eps (diluted) in 2023?
BridgeBio Pharma annual eps (diluted) for 2023 was $-3.95, a 21.17% decline from 2022.
- Company
- BridgeBio Pharma
- Ticker
- BBIO
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations